Lannett competitors

Zippia score 4.8

Lannett main competitors are Nostrum Laboratories, Johnson & Johnson, and Ranbaxy Pharmaceuticals Inc.

Competitor Summary. See how Lannett compares to its main competitors:

Johnson & Johnson has the most employees (134,500).
Employees at Nostrum Laboratories earn more than most of the competitors, with an average yearly salary of $77,111.

Work at Lannett?

Share your experience

Lannett vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Lannett	1942	4.8	Philadelphia, PA	3	$340.6M	1,020
Impax Laboratories	1993	4.9	Hayward, CA	1	$775.8M	1,257
Kremers Urban Pharmaceuticals	1904	4.5	Princeton, NJ	1	$5.0B	7,500
Akorn	1971	4.8	Lake Forest, IL	7	$682.4M	2,227
Par Pharmaceutical Inc	2003	4.9	Spring Valley, NY	4	$260.0M	400
Ranbaxy Pharmaceuticals Inc	2004	4.6	Princeton, NJ	1	$680.0M	1,000
Johnson & Johnson	1886	4.7	New Brunswick, NJ	26	$88.8B	134,500
Nostrum Laboratories	1995	4.0	Kansas City, MO	1	$15.0M	148
Sandoz	1946	4.5	Princeton, NJ	5	$21.0M	34
CorePharma	1995	4.3	Middlesex, NJ	1	$15.0M	200
Tapemark	1952	4.2	Saint Paul, MN	1	$57.7M	200
Coldstream Labs	2007	4.2	Lexington, KY	1	$3.5M	50
Mallinckrodt	1867	4.8	Hazelwood, MO	5	$1.0B	3,400
Sun Pharmaceutical Industries Inc.	1984	4.6	Cranbury, NJ	3	$4.2B	32,000
Mylan	1961	4.8	Canonsburg, PA	2	$11.5B	35,000
Catalent Pharma Solutions	2007	4.4	Somerset, NJ	14	$4.4B	14,000
DPT Laboratories	1938	4.9	San Antonio, TX	1	$320.0M	510
US Pharma Lab	1996	4.5	North Brunswick, NJ	1	$202.0M	150
Ani Pharmaceuticals	1996	4.4	Baudette, MN	1	$614.4M	601
Quidel	1979	4.7	San Diego, CA	3	$1.7B	1,500
PharmaForce Inc.	-	4.2	New Albany, OH	1	$6.5M	84

Rate how well Lannett differentiates itself from its competitors.

Lannett salaries vs competitors

Among Lannett competitors, employees at Nostrum Laboratories earn the most with an average yearly salary of $77,111.

Compare Lannett salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Lannett	$67,940	$32.66	-
Impax Laboratories	$54,971	$26.43	-
Kremers Urban Pharmaceuticals	$48,108	$23.13	-
Akorn	$62,397	$30.00	-
Par Pharmaceutical Inc	$61,975	$29.80	-
Ranbaxy Pharmaceuticals Inc	$74,276	$35.71	-

Compare Lannett job title salaries vs competitors

Company	Highest salary	Hourly salary
Lannett	$108,507	$52.17
Quidel	$105,273	$50.61
Johnson & Johnson	$104,232	$50.11
Sun Pharmaceutical Industries Inc.	$99,325	$47.75
Impax Laboratories	$97,203	$46.73
Catalent Pharma Solutions	$93,758	$45.08
Sandoz	$92,993	$44.71
Nostrum Laboratories	$92,021	$44.24
Mylan	$91,735	$44.10
Mallinckrodt	$91,156	$43.82
Par Pharmaceutical Inc	$88,391	$42.50
Tapemark	$87,502	$42.07
Coldstream Labs	$82,917	$39.86
CorePharma	$82,850	$39.83
US Pharma Lab	$82,305	$39.57
Ani Pharmaceuticals	$82,145	$39.49
DPT Laboratories	$81,859	$39.36
Akorn	$81,786	$39.32
Ranbaxy Pharmaceuticals Inc	$81,728	$39.29
Kremers Urban Pharmaceuticals	$81,296	$39.08

Do you work at Lannett?

Does Lannett effectively differentiate itself from competitors?

Lannett jobs

Lannett demographics vs competitors

Compare gender at Lannett vs competitors

Job title	Male	Female
Akorn	54%	46%
Ani Pharmaceuticals	55%	45%
Catalent Pharma Solutions	57%	43%
Johnson & Johnson	58%	42%
Quidel	58%	42%
Lannett	72%	28%

Male

Female

100%

75%

50%

25%

Lannett

Quidel

Johnson & Johnson

Catalent Pharma Solutions

Ani Pharmaceuticals

Akorn

25%

50%

75%

100%

Compare race at Lannett vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Lannett	58%	13%	9%	16%	3%	9.4
Akorn	61%	15%	11%	9%	4%	9.4
Ani Pharmaceuticals	61%	6%	21%	9%	3%	9.4
Catalent Pharma Solutions	60%	16%	10%	9%	4%	9.7
Johnson & Johnson	54%	16%	10%	15%	4%	9.8
Quidel	50%	24%	8%	14%	5%	9.8

Lannett revenue vs competitors

Lannett revenue is $340.6M. Among it's competitors, the company with the highest revenue is Johnson & Johnson, $88.8B . The company with the lowest revenue is Coldstream Labs, $3.5M.

Lannett and similar companies CEOs

CEOBio

Douglas S. Boothe

Akorn

C-Level Executive with demonstrated leadership skills and proven business results in Pharmaceuticals (Branded and Generics), Sales, Marketing, Operations, Business Development, R&D/Regulatory.I'm a creative problem-solver, with a track record of outstanding results through professional and interpersonal skills including strategic vision, team development, people management, prioritization, motivation, decisiveness and grit.

Nikhil Lalwani

Ani Pharmaceuticals

Nikhil Lalwani is a Board Member at ANI PHARMACEUTICALS INC and President/CEO at ANI PHARMACEUTICALS INC. He has worked as Chief Executive Officer at Cipla USA Inc.. Nikhil studied at Georgia Tech and The Wharton School.

Larry Hsu

Impax Laboratories

Joaquin Duato

Johnson & Johnson

Douglas C. Bryant

Quidel

Douglas C. Bryant became President and Chief Executive Officer on March 1, 2009. Prior to joining Quidel, Mr. Bryant served as Executive Vice President and Chief Operating Officer at Luminex Corporation, managing its Bioscience Group, Luminex Molecular Diagnostics (Toronto), manufacturing, R&D, technical operations, and commercial operations. From 1983 to 2007, he held various worldwide commercial operations positions with Abbott Laboratories including, among others: Vice President of Abbott Vascular for Asia/Japan, Vice President of Abbott Molecular Global Commercial Operations and Vice President of Abbott Diagnostics Global Commercial Operations. Earlier in his career with Abbott, Mr. Bryant was Vice President of Diagnostic Operations in Europe, the Middle East and Africa, and Vice President of Diagnostic Operations Asia Pacific. Mr. Bryant holds a B.A. in Economics from the University of California at Davis.

Mark Trudeau

Mallinckrodt

Heather Bresch

Mylan

Heather Manchin Bresch (Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn. In 2015, she was listed as #22 in Fortune magazine's “Most Powerful Women” list.

the Sandoz Executive Committee Is Responsible For Overseeing the Business Operations of Sandoz. the Sec Is Made Up of A Diverse Team of Leaders With Extensive Experience In the Generic Pharmaceutical and Biopharmaceutical Industry. Each Member of the Sec Represents A Specific Region Under the Leadership of Richard Saynor Business Unit Or Global Function. They Share A Commitment To Helping People Around the World Access High Quality Medicine. (SEC)

Sandoz

Richard Saynor is a CEO at Sandoz.

Abhay Gandhi

Sun Pharmaceutical Industries Inc.

Arpit Patel

CorePharma

Arpit Patel is an Associate Director, Quality Assurance and Compliance at Aurolife Pharma LLC and Chief Executive Officer & Board Member at CorePharma LLC and is based in Dayton, New Jersey. He has worked as Quality Engineer, Quality Compliance at 29 Consulting LLC - Vascular Therapies, Inc; Quality Assurance Consultant at CorePharma LLC; and Acting Director, Quality Assurance and Compliance at Aurolife Pharma LLC. Arpit attended Fairleigh Dickinson University-Metropolitan Campus between 2007 and 2009; Gujarat University, L M College of Pharmacy; and Telnet between 2002 and 2006.